http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05e20cb073869710f813cc85780c17a7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Minucci |
| name | Saverio Minucci |
| given-name | Saverio |
| organization-name | 7Department of Experimental Oncology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.; 13Department of Biosciences, University of Milan, Milan, Italy. From the Robert H. Lurie Comprehensive Cancer Center and Division of Hematology-Oncology, Northwestern University School of Medicine and Lakeside VA Medical Center, and the Section of Hematology-Oncology, University of Chicago, IL; the Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago; and the Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy; Department of Biomolecular Sciences and Biotechnologies, University of Milan, Via Celoria 26, 20133 Milan, Italy Department of Experimental Oncology at the European Institute of Oncology, IFOM-IEO Campus, Via Adamello 16, I-20100 Milan, Italy; Department of Biosciences, University of Milan, Via Celoria 26, I-20100 Milan, Italy Department of Experimental Oncology at the IFOM‐IEO Campus European Institute of Oncology Milan Italy; Department of Biosciences University of Milan Milan Italy Department of Biosciences, University of Milan, Via Celoria 26, 20100 Milan, Italy; Department of Experimental Oncology at the IEO, European Institute of Oncology IRCCS, IFOM-IEO Campus, Via Adamello 16, 20100 Milan, Italy Department of Experimental Oncology, European Institute of Oncology, Milan, Italy;; Drug Development Program, European Institute of Oncology, Milan, Italy; and; Department of Biosciences, University of Milan, Milan, Italy 1Department of Experimental Oncology, European Institute of Oncology, Milan 20141, Italy Department of Experimental Oncology, Academic Drug Discovery, European Institute of Oncology, Via Adamello 16, 20139 Milano, Italy; Department of Biosciences, University of Milan, Via Celoria, 26, 20133 Milano, Italy Department of Experimental Oncology at the IFOM-IEO Campus, European Institute of Oncology, Milan, Italy;; Department of Biosciences, University of Milan, Milan, Italy Department of Experimental Oncology, European Institute of Oncology, Milan 20139, Italy; New Drugs Program, European Institute of Oncology, Milan 20139, Italy; Department of Biosciences, University of Milan, Milan 20133, Italy Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. Laboratory of Molecular Growth and Regulation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892 1Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.; 9Department of Biosciences, University of Milan, Milan, Italy. Laboratory of Molecular Growth Regulation, Corvallis, Oregon 97331 European Institute of Oncology, Milan, Italy European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy; Department of Biomolecular Sciences and Biotechnologies, University of Milan, Via Celoria, 26, 20133 Milan, Italy Centre de Regulacio Genomica, Universitat Pompeu Fabra, Passeig Maritim 37-49, 08003 Barcelona, Spain; European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy; and Institució Catalana de Recerca i Estudis Avançats and Centre de Regulacio Genomica, Passeig Maritim 37-49, 08003 Barcelona, Spain Department of Experimental Oncology European Institute of Oncology (IEO) Milan Italy; Department of Biosciences University of Milan Milan Italy Authors' Affiliations: 1Department of Experimental Oncology, European Institute of Oncology, 2Fondazione IFOM (Istituto FIRC di Oncologia Molecolare), IFOM-IEO, 3Department of Biomolecular Sciences and Biotechnologies, University of Milan, Milan, Italy; Authors' Affiliations: 1Department of Experimental Oncology, European Institute of Oncology, 2Fondazione IFOM (Istituto FIRC di Oncologia Molecolare), IFOM-IEO, 3Department of Biomolecular Sciences and Biotechnologies, University of Milan, Milan, Italy Department of Experimental Oncology, European Institute of Oncology, Milan, Italy;; Department of Biomolecular Sciences and Biotechnology, University of Milan, Milan, Italy Department of Experimental Oncology IEO European Institute of Oncology IRCCS Milan Italy; Department of Biosciences University of Milan Milan Italy Department of Experimental Oncology, European Institute of Oncology IEO, Via Adamello 16, 20139 Milan, Italy; Department of Biosciences, University of Milan, 20100 Milan, Italy bol University of Milan , Department of Experimental Oncology , European Institute of Oncology and Department of Biosciences , Milan , Italy. Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; Department of Biosciences, University of Milan, Milan, Italy Department of Experimental Oncology, European Institute of Oncology, IEO, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy Department of Experimental Oncology, European Institute of Oncology, Milan, Italy 5Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy. Authors' Affiliations: 1Fondazione Istituto FIRC di Oncologia Molecolare (IFOM); 2European Institute of Oncology; 3DSBB-Università degli Studi di Milano, Milan, Italy; Authors' Affiliations: 1Fondazione Istituto FIRC di Oncologia Molecolare (IFOM); 2European Institute of Oncology; 3DSBB-Università degli Studi di Milano, Milan, Italy Authors' Affiliations: 1Gene Regulation Laboratory, 2Translational Research Laboratory, Cancer Therapeutics Program, The Peter MacCallum Cancer Institute, St. Andrews Place, East Melbourne; 3Walter and Eliza Hall Institute; 4The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; 5Merck Research Laboratories, Boston, Massachusetts; 6Department of Experimental Oncology, European Institute of Oncology; and 7University of Milan, Milan, Italy; Authors' Affiliations: 1Gene Regulation Laboratory, 2Translational Research Laboratory, Cancer Therapeutics Program, The Peter MacCallum Cancer Institute, St. Andrews Place, East Melbourne; 3Walter and Eliza Hall Institute; 4The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia; 5Merck Research Laboratories, Boston, Massachusetts; 6Department of Experimental Oncology, European Institute of Oncology; and 7University of Milan, Milan, Italy 3Department of Biomolecular Sciences and Biotechnologies, University of Milan;; 4Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; and Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.; Department of Biosciences, University of Milan, Milan, Italy. Department of Experimental Oncology IEO – European Institute of Oncology IRCCS via Adamello 16 20139 Milan Italy; Department of Biosciences University of Milan Via Festa del Perdono 7 20122 Milano Italy Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy Department of Experimental Oncology, European Institute of Oncology Milan Italy; Department of Biomolecular Sciences and Biotechnology, University of Milan Milan Italy 2Department of Experimental Oncology, European Institute of Oncology, Milan, Italy Department of Experimental Oncology, Academic Drug Discovery, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy; Department of Biosciences, University of Milan, Via Celoria 26, 20133 Milan, Italy 6Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. Department of Experimental Oncology, Academic Drug Discovery, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy; Department of Biosciences, University of Milan, Via Celoria, 26, 20133 Milan, Italy Department of Experimental Oncology, European Institute of Oncology, 20139 Milan, Italy;; Department of Biomolecular Sciences and Biotechnologies, University of Milan, 20100 Milan, Italy Department of Experimental and Diagnostic Medicine, Section of General Pathology and Interdisciplinary Center for the Study of Inflammation (ICSI), University of Ferrara, Ferrera, Italy.; Emilia Romagna Laboratory for Genomics and Biotechnology (ER-Gentech), University of Ferrara, Ferrera, Italy.; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.; Fondazione Italiana per la Ricerca sul Cancro (FIRC) Institute of Molecular Oncology, Milan, Italy.; Congenia s.r.l., Milan, Italy. Division of Early Drug Development, European Institute of Oncology, Milan, Italy; Department of Oncology and Hematology, University of Milan, Milan, Italy From the European Institute of Oncology, Department of Experimental Oncology, Milan, Italy; Department of Physiology and General Biochemistry, and Department of Veterinary Pathology, Hygiene and Public Health, School of Veterinary Medicine, University of Milan, Italy; IFOM-FIRC Institute of Molecular Oncology, Milan, Italy; and Department of Human Biotechnology and Hematology, University of Rome “La Sapienza,” Rome, Italy. Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy From the Laboratorio di Patologia Vascolare (C.G., A.C., B.I., A.F., R.P., F.F., A.M., S.M., J.M., M.C.C.), Istituto Dermopatico dell’Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy; Sezione di Patologia Clinica (A.C.), Dipartimento di Oncologia e Neuroscienze, Facoltà di Medicina e Chirurgia, Università “G. D’Annunzio”, Chieti, Italy; and Dipartimento di Oncologia Sperimentale (S.M.), Istituto Oncologico Europeo, Milan, Italy. Department of Experimental Oncology, European Institute of Oncology, Milan, Italy; Department of Experimental Oncology, European Institute of Oncology, 20141 Milan, Italy Department of Experimental Oncology, Academic Drug Discovery, European Institute of Oncology, Ifom-IEO-Campus, via Adamello 16, 20139 Milan, Italy; Department of Biosciences, University of Milan, Via Celoria, 26, 20133 Milan, Italy Dipartimento di Oncologia Sperimentale, IEO−European Institute of Oncology, Via Adamello 16, 20139 Milano, Italy; Department of Biosciences, University of Milan, 20100 Milan, Italy From the European Institute of Oncology, the Department of Experimental Oncology, Milan; Istituto Nazionale Tumori, Divisione Oncologia Sperimentale D, Milan; Istituto di Clinica Medica I, University of Perugia, Perugia; and Universita’ ‘La Sapienza,” Istituto di Istologia, Rome, Italy. Department of Experimental Oncology, Academic Drug Discovery, European Institute of Oncology, Via Adamello 16, 20139 Milano, Italy; Department of Biosciences, University of Milan, Via Celoria 26, 20133 Milano, Italy Early Drugs Development for Innovative Therapies Division, European Institute of Oncology, Milan, Italy; School of Medicine, University of Milano, Milan, Italy Laboratory of Molecular Growth RegulationNational Institute of Child Health and Human DevelopmentNational Institutes of HealthBethesdaMaryland20892USA Department of Genetics and Microbiology, University of Pavia, Via Ferrata 1, 27100 Pavia, Italy, Department of Drug Chemistry and Technologies, University “La Sapienza”, P.le A. Moro 5, 00185 Roma, Italy, European Institute of Oncology, Via Adamello 16, 20139 Milan, Italy, Italian National Institute of Health, Department of Therapeutic Research and Medicines Evaluation, Via Regina Elena 299, 00161 Roma, Italy, Department of Biochemistry, Emory University, 1510 Clifton Road, Atlanta, Georgia 30322, and... Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, and Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 |
Incoming Links
Total number of triples: 233.